Collaborates Archives

Takeda and Frazier Healthcare Collaborate to Launch a Facility Phathom Pharmaceutical for Gastrointestinal Disorders

May 16, 2019May 17, 2019Tuba Khan

Shots: Takeda and Frazier enter into collaboration to launch Phathom Pharmaceuticals to develop & commercialize therapies for gastrointestinal diseases and disorders Phathom to [...]

Abbott Collaborates with NIH on Brain Initiative for Advancing Research on Neurological Disorders

May 15, 2019May 16, 2019Tuba Khan

Shots: Abbott to provide its neuromodulation technologies including deep brain stimulation (DBS), spinal cord stimulation (SCS), and dorsal root ganglion (DRG) therapy. NIH [...]

Gilead Collaborates with Goldfinch Bio to Develop and Commercialize Therapies for Kidney Disorders

May 9, 2019May 10, 2019Tuba Khan

Shots: Goldfinch to receive $55M upfront including $5M equity investment, $1.95B milestones for the first five opted programs and royalties on sales of [...]

Takeda Collaborates with Skyhawk Therapeutics to Develop RNA Splicing Modifiers for Neurodegenerative Diseases

May 7, 2019May 10, 2019Tuba Khan

Shots: Skyhawk to receive upfront, milestones & royalties on sales and will discover & preclinically develop targeted therapies utilizing its SkySTAR technology. Takeda [...]

Celgene Collaborates with Presage to Evaluate Therapies with its CIVO Technology for Multiple Cancers

May 3, 2019May 7, 2019Tuba Khan

Shots: Presage utilizes its CIVO intratumoral microdosing platform to evaluate Celgene’s early stage products in P-0 trial The collaboration follows safety & feasibility [...]

AstraZeneca Collaborates with BenevolentAI to Develop Therapies for Chronic Kidney Disease and Idiopathic Pulmonary Fibrosis

April 30, 2019May 2, 2019Tuba Khan

Shots: AstraZeneca & BenevolentAI enter into an agreement to discover & develop therapies for chronic kidney disease (CKD) and idiopathic pulmonary fibrosis (IPF) [...]

Collaborates

Takeda and Frazier Healthcare Collaborate to Launch a Facility Phathom Pharmaceutical for Gastrointestinal Disorders

Abbott Collaborates with NIH on Brain Initiative for Advancing Research on Neurological Disorders

Gilead Collaborates with Goldfinch Bio to Develop and Commercialize Therapies for Kidney Disorders

Takeda Collaborates with Skyhawk Therapeutics to Develop RNA Splicing Modifiers for Neurodegenerative Diseases

Celgene Collaborates with Presage to Evaluate Therapies with its CIVO Technology for Multiple Cancers

AstraZeneca Collaborates with BenevolentAI to Develop Therapies for Chronic Kidney Disease and Idiopathic Pulmonary Fibrosis

Janssen Collaborates with Iktos for its Artificial Intelligence (AI) Technology

Almac Diagnostic Collaborates with Queen’s University to Bring Personalized Chemotherapy for Esophageal Cancer

Mylan and TB Alliance Collaborate to Commercialize Pretomanid in Two Combination Regimens for Tuberculosis

Boehringer Ingelheim Collaborates with PureTech to Develop Immuno-Oncology Candidates for Immune Modulation